Change in Nutritional and Biochemical Status in People Living with HIV-1 on Antiretroviral Therapy

Viruses. 2022 Nov 20;14(11):2573. doi: 10.3390/v14112573.

Abstract

Antiretroviral therapy (ART) improves the quality of life of people living with HIV-1 (PLHIV) and reduces the mortality rate, but some individuals may develop metabolic abnormalities. This study evaluated changes in the nutritional status and biochemistry of PLHIV on antiretroviral therapy in a cohort that had not previously received ART and to follow up these individuals for 24 months after starting treatment. The initial cohort consisted of 110 individuals and ended with 42 people, assessed by a physical examination. A biochemical assay was performed using the colorimetric enzyme reaction technique, the proviral load was detected by qPCR and the quantification of the CD4/CD8 T lymphocytes was conducted by flow cytometry. PLHIV had increased levels of total cholesterol, LDL, triglycerides, ALT, urea and creatinine after 24 months of ART use (p < 0.05). In the assessment of the nutritional status, PLHIV had increased measures of Triciptal Skinfold, body mass index and arm circumference after the use of ART (p < 0.05). The viral load levels decreased and the CD4 levels increased after 24 months of ART use (p < 0.05). The change in the nutritional status in PLHIV on antiretroviral therapy seems to be a slow process, occurring in the long term, therefore, there is the need for a constant evaluation of these people to identify patients who need a nutritional intervention.

Keywords: ART; HIV-1; anthropometry; biochemical parameters; immunological markers; nutritional profile.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • HIV Infections* / drug therapy
  • HIV Seropositivity*
  • HIV-1*
  • Humans
  • Quality of Life
  • Viral Load

Grants and funding

Universidade Federal do Pará (PAPQ/2022). RI (#312979/2018-5) and ACRV (#302935/2021-5) are Research Grantees of the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).